Drug News

Neosalus Cream available for dermatitis

March 16, 2010

Quinnova announced the launch of Neosalus Cream, a non-steroidal anti-inflammatory cream for the treatment of various dermatoses (eg, atopic dermatitis, contact dermatitis, and hand eczema).
 

Five-day dosing regimen for Dacogen approved for myelodysplastic syndromes (MDS)

March 12, 2010

The FDA has approved a five-day dosing regimen for Dacogen (decitabine for injection, from Eisai) to treat patients with myelodysplastic syndromes (MDS).
 

Trelstar 22.5mg approved for palliative treatment of prostate cancer

March 11, 2010

The FDA has approved Trelstar 22.5mg (triptorelin pamoate for injectable suspension, from Watson) for the palliative treatment of advanced prostate cancer.
 

Botox approved for upper limb spasticity

March 10, 2010

The FDA has approved Botox (onabotulinumtoxin A, from Allergan) for the treatment of spasticity in the flexor muscles of the elbow, wrist, and fingers in adults.
 

Pediaderm HC Complete Kit available for atopic dermatitis

March 09, 2010

Arbor Pharmaceuticals announced the launch of Pediaderm HC Complete Kit which contains Pediaderm HC (hydrocortisone lotion 2%) and nonsteroidal Pediaderm Protective Emollient with Triple Synergy Technology.
 

Drug Safety Alerts and Recalls

FDA warns of reduced Plavix efficacy in poor metabolizers

March 15, 2010

The FDA has notified healthcare professionals and patients that a Boxed Warning has been added to the Plavix (clopidogrel tablets, from Bristol-Myers Squibb and Sanofi) Prescribing Information to include information about reduced Plavix efficacy in patients who are poor metabolizers of Plavix.
 

FDA reviews atypical subtrochanteric femur fractures risk with oral bisphosphonates

March 11, 2010

The FDA has notified healthcare professionals and patients that at this point, the data that have been reviewed have not shown a clear connection between bisphosphonate use and a risk of atypical subtrochanteric femur fractures.
 

Drugs in the Pipeline

FDA accepts NDA for lurasidone, a treatment for schizophrenia

March 11, 2010

Dainippon Sumitomo Pharma America announced that the FDA has accepted for filing the New Drug Application (NDA) submitted for lurasidone for the treatment of schizophrenia.
 

Phase 3 study of Anturol for the treatment of overactive bladder (OAB)

March 02, 2010

Antares Pharma announced that it has completed enrollment in the double-blind portion of their Phase 3 trial of Anturol (transdermal oxybutynin ATD gel) for the treatment of overactive bladder (OAB).
 

New Drug Products

Updated Charts

Bowel Cleansers

March 16, 2010

Bowel cleansing products used for colonoscopy preparation.
 

Recommended Adult Immunization Schedule

March 02, 2010

This schedule indicates the recommended age groups and medical indications for routine administration of currently licensed vaccines for persons 19 years and older.
 

Antiemetic Medications

February 05, 2010

A list of drugs used for the treatment of nausea. The chart includes the formulations, strengths, and usual doses for each antiemetic drug product.
 

Catch-Up Immunization Schedule for Children

February 02, 2010

A catch-up immunization schedule for children 4 months to 18 years of age. The tables show minimum intervals between doses for children who have delayed immunizations.
 

Recommended Immunization Schedule for Ages 0 to 18 Years

January 21, 2010

This schedule indicates the recommended ages for routine administration of currently licensed childhood vaccines for children through age 18 years.
 

How important are herbals and supplements
to your practice?

Please take this short survey

and let us know.

COLORECTAL CANCER AWARENESS MONTH


This March, MPR is honoring
Colorectal Cancer Awareness Month
with a special drug information newsletter containing state-of-the-art information on the diagnosis, treatment, and prevention for colorectal cancer, as well as intriguing new research

View this month's MPR Seasonal Spotlight

Subscribe to the MPR Seasonal Spotlight

SPECIALTY



Coming Soon
COMPARE FUNCTION


  • Easy-to access, drop down window allows comparison to similar drugs!
  • Compare any number of drug products
  • All fields within the drug monograph can be scanned easily

Compare Drugs Function Instructions 

Download the MPR Mobile & Desktop Edition for free access to over 4,000 up-to-date, concise drug monographs on your computer or mobile device.

Updated Drugs

PROTONIX TABLETS

Gastrointestinal Tract > Hyperacidity, GERD, and ulcers

Children: added dosing for erosive esophagitis. Interactions: added concomitant atazanivir or nelfinavir: not recommended.

Updated: 3/17/2010

 

LAMICTAL XR

Central Nervous System > Seizure disorders

Indications: added adjunct in primary generalized tonic-clonic seizures.

Updated: 3/16/2010

 

TEV-TROPIN

Endocrine System > Pituitary disorders

Monograph added.

Updated: 3/15/2010

 
Click here to let us know what you are looking for.

Top 25 Searched Drugs

  1. Prozac
  2. Prinivil
  3. Glucophage
  4. Valium
  5. Effexor
  6. Xanax
  7. Abilify
  8. Toprol-XL
  9. Hytrin
  10. Tenormin
  1. Norvasc
  2. Diovan
  3. Flexeril
  4. Neurontin
  5. Lexapro
  6. Lipitor
  7. Ultram
  8. Tylenol
  9. Zithromax
  10. Zocor
  11. Celexa
  12. Zyrtec
  13. Bactrim
  14. Flomax
  15. Prednisone
 Subscribe to the RSS for this page  [view all our RSS feeds here]